Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance Brian EdwardsBruce HugmanMatthew Whalen Current Opinion 09 January 2013 Pages: 265 - 271
Safety of Flecainide Juan TamargoAlessandro CapucciPhilippe Mabo Review Article 09 January 2013 Pages: 273 - 289
Deriving Dose Limits for Warnings in Electronic Prescribing Systems Jamie J. ColemanJames HodsonRobin E. Ferner Short Communication 09 January 2013 Pages: 291 - 298
Risk Minimization Activities of Centrally Authorized Products in the EU Inge M. ZomerdijkFakhredin A. Sayed-TabatabaeiSabine M. J. M. Straus Original Research Articles 09 January 2013 Pages: 299 - 314
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones Domenico MotolaCarlo PiccinniElisabetta Poluzzi Original Research Articles 09 January 2013 Pages: 315 - 323
Assessing Opioid Shopping Behaviour M. Soledad CepedaDaniel FifeScott C. Henderson Original Research Articles 09 January 2013 Pages: 325 - 334
Vaccine-Based Subgroup Analysis in VigiBase Sandra de BieKatia M. C. Verhammeon behalf of the TEDDY European Network of Excellence Original Research Articles 09 January 2013 Pages: 335 - 346